로딩 중…
지수 로딩 중…
BIOBIJOU Co.,Ltd.
489460· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩11,030+0.55%
2026-08-04
Financials
Valuation Metrics
BIOBIJOU Co.,Ltd.'s Market Cap is ₩1627B. Ranked #942 of 2,436 in KR market (top 39%), #452 of 1,649 on KOSDAQ (top 27%), #108 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 46%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 162.73B KRW | KR#942/2,436 Sec#108/234 |
| Revenue | 28.49B KRW | KR#2,048/2,436 Sec#144/234 |
| Net Income | 4.15B KRW | KR#1,188/2,436 Sec#79/234 |
| Total Assets | 63.75B KRW | KR#2,048/2,436 Sec#174/234 |
| Net Assets | 61.98B KRW | KR#1,725/2,436 Sec#150/234 |
| Value | ||
| P/E | 39.19x | KR#1,315/2,436 Sec#84/234 |
| P/B | 2.63x | KR#2,059/2,436 Sec#161/234 |
| P/S | 5.71x | KR#2,174/2,436 Sec#144/234 |
| EV/EBITDA | 35.74x | KR#1,250/2,436 Sec#86/234 |
| FCF Yield | -1.92% | KR—/2,436 Sec—/234 |
| Profitability | ||
| ROE | 6.70% | KR#826/2,436 Sec#61/234 |
| ROA | 6.51% | KR#477/2,436 Sec#35/234 |
| Op. Margin | 14.84% | KR#285/2,436 Sec#26/234 |
| Financial Health | ||
| Debt Ratio | 102.85% | KR#339/2,436 Sec#45/234 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/234 |
| FCF | -3.12B KRW | KR#1,401/2,436 Sec#109/234 |
| Cash | 11.64B KRW | KR#1,583/2,436 Sec#121/234 |
| Current Ratio | 30.20x | KR#11/2,436 Sec#6/234 |
| Net Debt/EBITDA | -2.75x | KR#222/2,436 Sec#11/234 |
| Dividend | ||
| Div. Yield | 0.91% | KR#1,158/2,436 Sec#71/234 |
| Performance | ||
| 1Y Return | -37.79% | KR#1,784/2,436 Sec#155/234 |
| 1M Return | 63.41% | KR#16/2,436 Sec#1/234 |
| From 52W High | -48.58% | KR#1,128/2,436 Sec#96/234 |
| 1Y MDD | -75.37% | KR#2,160/2,436 Sec#196/234 |
| Trading | ||
| Volume | 124,434 shares | KR#806/2,436 Sec#80/234 |
| Foreign Own. | 1.53% | KR—/2,436 Sec—/234 |
| Per Share | ||
| EPS | 365 KRW | KR#1,044/2,436 Sec#72/234 |
| BPS | 4,210 KRW | KR#1,578/2,436 Sec#119/234 |